Epoprostenol‐associated ascites in pulmonary arterial hypertension

The development of ascites in pulmonary arterial hypertension (PAH) in the absence of pre‐existing hepatic dysfunction is usually associated with decompensated right heart failure or cardiac cirrhosis. Ascites in PAH has rarely been associated with intravenous epoprostenol, a synthetic form of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenberg, Noah C., Ruopp, Nicole F., Parikh, Raj D., Farber, Harrison W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248792/
https://www.ncbi.nlm.nih.gov/pubmed/35795488
http://dx.doi.org/10.1002/pul2.12092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248792/
https://www.ncbi.nlm.nih.gov/pubmed/35795488
http://dx.doi.org/10.1002/pul2.12092

Ejemplares similares